NFKB1 and neoplasm: Each type of these cells has its own unique immunity, but their antitumor function is reduced in the tumor microenvironment, and the mechanism of sustained activation of the NF-κB pathway generation also appears to favor tumor survival and drive abortive activation of immune cells (92).